Non-Invasive Monitoring Device Market Analysis

It can generate and provide results of accurate body readings. The applications of the non-invasive medical device are pulse oximetry, Bp measurement, electrocardiogram and balder temperature checking. It is an essential monitoring system to identify the conditions such as cardiac disorder and cancer. Also, the diabetes type 2 non-invasive monitoring devices are popular these days. The requirement for these non-invasive monitoring is rising at a rapid pace at the forecast period. The non-invasive monitoring device market growth is estimated at 6.80%. Also, the non-invasive monitoring device market value is assumed to be 21,586.2 Million. The demand for non-invasive is more than the demand for invasive monitoring is massive in 2023.

The C pro six non-invasive monitoring device is now being sold in the United States. The innovative device was designed for diabetic patients. The system is appropriate for diabetic patients over the age of two years.

The GLUCOCARD monitoring device is making its debut in America. It has been tailored to blood glucose monitoring applications.

For instance, in November 2022- ResMed opened a new manufacturing center in Singapore to build its global footprint that supports the development, growth, and production of digital health solutions.

In February 2024, Know Labs announced the release of KnowU, their newest wearable non-invasive continuous glucose monitor (CGM). This includes enhanced performance features like rechargeable battery and mobile application support, which makes it user-friendly. In fact, this eight-month accelerated product development process led up to the release of the first prototype in June 2023. The device incorporates a proprietary sensor that showed stability and accuracy when tested on lab settings before being made tiny enough for wearing purposes.

In January 2024, Spiden—a renowned pioneer in non-invasive biomarker technology—celebrated an important scientific milestone as well as an oversubscribed convertible note and major news on our executive team additions. Spiden has made huge scientific strides towards non-invasive sensing of glucose. By utilizing advanced spectroscopy techniques in a portable format, a combined effort by its scientists has resulted in an individual calibration MARD of nine percent (mean absolute relative difference – average difference to gold-standard measurement). This is another significant step forward, leading towards calibration-free miniaturized devices intended for non-invasive detection of sugar levels under the skin.

On May 25th, 2023, In contrast with existing invasive continuous glucose monitors available within the market, GWave measures blood sugars instead of interstitial fluids that cause lag time between readings. Measuring blood sugar allows greater accuracy, which means individuals at risk or suffering from diabetes can monitor their glucose levels without having to be pricked on a daily basis. When it comes to accuracy, the GWave device is one-third of the size of a smartphone and has significantly reduced radio frequency exposure compared to average smartphones.

Covid analysis 

Covid 19 has caused unexpected changes in the non-invasive monitoring device market. However, the medical industry is facing massive demand during this period. The rising demand for medical devices and technology is at its peak. The Non-invasive Blood Glucose Monitoring Devices Market is witnessing exceptional growth opportunities.

The requirement of the non-invasive monitoring systems health blood is high. The supply of non-invasive health monitor has been increased to meet immense market demand. The non-invasive monitoring device is also used in the covid critical care centres. It is helpful to monitor the patients and their recovery from the coronavirus. Also, the significance of this technology is rising more in the future years. Further, even during the pandemic and post covid 19, the non-invasive monitoring device market trends remain steady. The crucial market players of the non-invasive monitoring device market are taking advantage of the current situation to earn more profits. All this contributes to a positive impact on the Non-invasive Blood Glucose Monitoring Devices Market. 

Non-Invasive Monitoring Device Market Trends

• The crucial market drivers 

Non-invasive monitoring is high-end technology. Unlike any other medical devices, the awareness about this device is higher. The requirement of the blood monitoring system is massive in the medical industry. The blood monitoring devices are helpful to monitor the blood sugar levels of a diabetes patient.

Today, more than millions of individuals are suffering from diabetes. Also, the rate of diabetes patients is increasing every year. It is causing a serious need for non-invasive Prenatal Testing systems. The availability of non-invasive monitoring device both in public and private clinics are crucial Non-invasive Blood Glucose Monitoring Devices Market drivers. Furthermore, there are several initiatives by the government to reduce the rate of a diabetes patient. These initiatives ultimately raise the demand for monitoring devices. The immense population of diabetes patients in Asia and North America are another driving factor. 

• The market growth opportunities 

Today, the use of invasive monitoring device is versatile. It is used for plenty of monitoring procedures. The speciality of this non-invasive device is the sensors. The device does require skin penetration. With the sensors, the device can provide the results of the patient. The hassle-free properties of the device offer plenty of future scopes. Also, there are varieties such as the brain, cardiac, blood, anesthesia and neurology non-invasive monitoring devices. The prevalence of people having these disorders is increasing. It is creating future growth opportunities for the non-invasive monitoring market.

Furthermore, in the upcoming years, technological advancement in the healthcare sector is massive. The adoption rate of these technologies also rises ever higher. The awareness and requirement of the monitoring devices provide exceptional growth opportunities. Also, the new developments in non-invasive devices will fuel the Non-invasive Blood Glucose Monitoring Devices Market growth. The new methods of non-invasive monitoring of intracranial pressure (ICP) are the future developments. 

• The market restraints 

The non-invasive monitoring device is sophisticated. The complexity of this medical device is a crucial restraint to the market. The adoption rate of this technology lows down due to device complexity. The readings of the non-invasive device are known as erroneous. It confuses while using the device in the healthcare sector. The wearable device is easier to operate than invasive monitoring devices.

However, there is a lack of awareness about its easy functions and benefits. These aspects are the most crucial restraining factors of the market. Also, the use of non-invasive monitoring device requires the approval of the government. However, in several regions, there are stringent government norms regarding the use. It is causing several restrictions in the overall non-invasive monitoring device market growth. 

• The market challenges 

The non-invasive monitoring device is a crucial part of developed countries medical infrastructure. However, the device is not a part of several healthcare centres in undeveloped regions. The requirement of these drives is high in the underdeveloped region. However, the awareness about the device is less in underdeveloped areas. It is causing several inconsistencies in the non-invasive monitoring device market.

The lack of awareness in undeveloped regions is a significant challenge of the market. There are several drawbacks due to this challenge. It restricts the non-invasive monitoring device market in the future years. Also, the non-invasive monitoring device industry requires more R&D for new developments. The non-invasive monitoring device market can survive better with the help of new development. Therefore, the significant market challenge is the lack of awareness in underdeveloped regions and fewer new developments. 

• Cumulative growth analysis 

The non-invasive monitoring device market is a flourishing market. The need for this device is growing at an exponential pace. There are plenty of drivers that propel the non-invasive monitoring device market growth. Also, there are plenty of potential growth opportunities that provide exceptional prospect. However, some factors hamper overall growth. The complexity in the device operations is a restraint. Also, the exposure of the non-invasive monitoring device is less in the underdeveloped regions. These factors can decline the on-invasive monitoring device industry demand in future years. However, the non-invasive monitoring device industry growth remains steady amidst all these factors. The new strategies of the key market players help in eliminating the challenges. Therefore, the cumulative growth analysis of the non-invasive monitoring device market is positive. 

• Value chain analysis 

North America holds the largest non-invasive monitoring device market share. The rate of diabetes patients is high in this region. The well-known segments are the neurodiagnostic and monitoring devices market in us. The demand in this region will intensify in the upcoming years. Also, the technology adoption rate is immense in North America.

Moreover, the expenditure on medical devices is higher than in any countries. The investments rate on Non-invasive monitoring device is massive in North America. All these aspects contribute to the overall market growth in this region. The governmental initiatives to promote the product are another on-invasive monitoring device industry driver. Non-invasive monitoring health biomarkers are surging in North America. Also, North America will be the highest contributing non-invasive monitoring device market. 

Non-Invasive Monitoring Device Market segments 

By type

• Cardiac monitors 


• Blood pressure monitor 


• Anaesthesia monitor 


• Elecrtocardiagroh monitor 


• Brain monitor 


• Blood gluacose monitor 

By Model

• Wearable device 


• Tabletop device

By application

• Oncology


• Cardiology


• Neurology

By region

North America 

• South America


• US 


• Canada 

Europe 

• Spain 


• Germany 


• Italy 


• France 


• UK 

Middle east 

• Qatar 


• Arabia 


• Oman 


• Kuwait 

Asia pacific 

• India 


• South Korea 


• China 


• Japan 


• Australia 

Regional analysis 

The non-invasive monitoring device is fragmented into North America, Asia Pacific, Middle East and Europe. North America holds its dominance during the forecast period. The Asia Pacific is known as the fastest-growing non-invasive monitoring device market. The prevalence of diabetes and cardio disorders is the crucial non-invasive monitoring device market drivers in this region. The increasing diabetes population in India is propelling the non-invasive monitoring device market growth.

Further, the approval of non-invasive monitoring device by the government is increasing market growth in Europe. The non-invasive monitoring device market in Europe has well-established players. The Middle East regions are another developing market. The share acquisitions are lower but the market growth is higher. There is plenty of awareness about non-invasive monitoring device in all these regions. The adoption rate is also higher in these regions. All these contribute to the high demand in this region. 

Competitive landscape 

The non-invasive monitoring device market is highly competitive. The demand is immense in the key regions. The launch of new development in this non-invasive monitoring device market is causing more demand. The adoption rate of the wearable monitoring device is higher during the forecasts period. 

The key players of the non-invasive, invasive monitoring are 

• Advanced Brain Monitoring


• General Electric


• medical


• Medtronic


• CNSystems Medizintechnik 


• Philips


• Integrity Applications


• OrSense


• Abbott


• Tensys Medical


• Omron


• A&D Medical


• Vaso Corporation


• CAS Medical Systems

Recent developments 

• The US market has launched the C pro 6 non-invasive monitoring device. The new device was developed for diabetes patient. The system is suitable for diabetes patients above the age of 2 years.  


• The key players of the market are conspiring plans to improve their product offering. It assures that there is going to be plenty of future developments.  


• The US market is introducing the GLUCOCARD monitoring device. It is specially developed for blood glucose monitoring applications. 

Report overview 

• Market overview highlights 


• Analysis based upon COVID 19


• Explanation upon the Market Dynamics


• Value chain analysis


• Market segmentation overview


• The regional analysis


• Competitive landscape analysis


• Recent Developments